Details for New Drug Application (NDA): 010104
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 010104 describes MEPHYTON, which is a drug marketed by Bausch and is included in one NDA. Additional details are available on the MEPHYTON profile page.
The generic ingredient in MEPHYTON is phytonadione. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
The generic ingredient in MEPHYTON is phytonadione. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 010104
| Tradename: | MEPHYTON |
| Applicant: | Bausch |
| Ingredient: | phytonadione |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
